GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $953,000 | +92.1% | 21,900 | +92.4% | 0.56% | +116.0% |
| Q1 2022 | $496,000 | -1.0% | 11,385 | +0.3% | 0.26% | +6.2% |
| Q4 2021 | $501,000 | +14.1% | 11,350 | -1.3% | 0.24% | +5.2% |
| Q3 2021 | $439,000 | -6.2% | 11,500 | -2.1% | 0.23% | -5.0% |
| Q2 2021 | $468,000 | +11.7% | 11,750 | 0.0% | 0.24% | +5.2% |
| Q1 2021 | $419,000 | +23.6% | 11,750 | +27.7% | 0.23% | +9.5% |
| Q4 2020 | $339,000 | -18.5% | 9,200 | -16.7% | 0.21% | -30.2% |
| Q3 2020 | $416,000 | -9.8% | 11,050 | -2.2% | 0.30% | -8.8% |
| Q2 2020 | $461,000 | +7.7% | 11,300 | 0.0% | 0.33% | -9.6% |
| Q1 2020 | $428,000 | -19.4% | 11,300 | 0.0% | 0.36% | +2.5% |
| Q4 2019 | $531,000 | +10.2% | 11,300 | 0.0% | 0.36% | +2.0% |
| Q3 2019 | $482,000 | +3.0% | 11,300 | -3.4% | 0.35% | +9.7% |
| Q2 2019 | $468,000 | -22.8% | 11,700 | -19.3% | 0.32% | -22.2% |
| Q1 2019 | $606,000 | +90.0% | 14,500 | +61.0% | 0.41% | +79.4% |
| Q4 2017 | $319,000 | -20.6% | 9,006 | -9.1% | 0.23% | -22.7% |
| Q3 2017 | $402,000 | -7.4% | 9,906 | -1.5% | 0.30% | -8.1% |
| Q2 2017 | $434,000 | -2.0% | 10,056 | -4.3% | 0.32% | -5.9% |
| Q1 2017 | $443,000 | +11.0% | 10,506 | +1.5% | 0.34% | +8.9% |
| Q4 2016 | $399,000 | -17.7% | 10,350 | -8.0% | 0.31% | -23.1% |
| Q3 2016 | $485,000 | +14.7% | 11,250 | +15.4% | 0.41% | +11.8% |
| Q2 2016 | $423,000 | +7.1% | 9,750 | 0.0% | 0.36% | +8.3% |
| Q1 2016 | $395,000 | -0.5% | 9,750 | -1.0% | 0.34% | -2.0% |
| Q4 2015 | $397,000 | -4.8% | 9,850 | -9.2% | 0.34% | -13.6% |
| Q3 2015 | $417,000 | -57.5% | 10,850 | -54.0% | 0.40% | -50.7% |
| Q2 2015 | $982,000 | -5.1% | 23,584 | +5.2% | 0.80% | -9.6% |
| Q1 2015 | $1,035,000 | -6.4% | 22,420 | -13.3% | 0.89% | -6.2% |
| Q4 2014 | $1,106,000 | +1.0% | 25,870 | +8.6% | 0.95% | -0.7% |
| Q3 2014 | $1,095,000 | +15.5% | 23,820 | +34.4% | 0.96% | +12.6% |
| Q2 2014 | $948,000 | +0.1% | 17,720 | 0.0% | 0.85% | -2.2% |
| Q1 2014 | $947,000 | -11.2% | 17,720 | -11.3% | 0.87% | -15.6% |
| Q4 2013 | $1,066,000 | – | 19,970 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |